Impact of mitochondrial genetics on muscle oxidative capacity, fitness, and mobility in older adults

线粒体遗传学对老年人肌肉氧化能力、健康和活动能力的影响

基本信息

  • 批准号:
    10522044
  • 负责人:
  • 金额:
    $ 47.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Older adults experience a loss of mobility that leads to disability, which is a serious health care issue in an aging US population. Furthermore, the incidence of mobility disability is greater in older African Americans compared to Caucasians. The mechanisms behind these observations are not well understood. We have shown that mitochondrial function is a key property of skeletal muscle that supports walking speed, physical function, and cardiorespiratory fitness in older adults. Cross-sectional and longitudinal studies reveal lower levels of mitochondrial content and function, lower cardiorespiratory fitness and slowing walking speed with aging. We recently demonstrated lower mitochondrial function in skeletal muscle in African American compared to Caucasian women that is associated with lower cardiovascular fitness and metabolic rate. The role of mitochondrial DNA (mtDNA) in age related changes in muscle oxidative capacity has not been explored. Our novel preliminary data suggest that mtDNA haplotype is an important determinant of lower mitochondrial function and cardiovascular fitness in African Americans. We have also shown that mtDNA variants are associated with walking speed in older AA and C adults. Furthermore, recent studies have revealed that change in peak VO2 in response to an exercise training program is associated with mtDNA haplogroup. Based on these observations we hypothesize that mtDNA haplotype plays an important role in cross sectional variation and more importantly, longitudinal declines in mitochondrial function, cardiovascular fitness, and walking speed in older adults. Variations in mtDNA that have been shown to impact aging phenotypes can be divided into 1) inherited variants, which are maternally inherited single nucleotide polymorphisms (SNPs), many of which differentiate the mtDNA haplogroups, and many that do not, or 2) acquired variation including heteroplasmy, or percentage of mutated vs normal mtDNA at any site across genome and decreased mtDNA copy number that occurs with aging. This ancillary study to The Study of Muscle, Mobility, and Aging will explore the role of inherited and acquired variations in mtDNA in mitochondrial function from muscle biopsies in a large cohort of well phenotyped humans. We will also explore the role of nuclear encoded mitochondrial proteins (NEMP) and crosstalk between mitochondrial DNA and Nuclear DNA in the mitochondrial and physiological differences observed. We will relate these findings to the clinically important endpoint of mobility in the entire cohort, as well as the role in the greater mobility declines in mobility in African Americans. Our study will be the first to show that mtDNA variation is predictive of greater declines in mitochondrial and physiological function, which are associated with mobility disability. These findings could allow us to assess mtDNA variation using a simple blood draw to identify those at risk for low function and to implement targeted therapies, e.g., physical activity, which has been shown to improve mitochondrial function.
项目总结 老年人失去行动能力会导致残疾,这是一个严重的医疗保健问题 美国人口老龄化。此外,老年非裔美国人中行动不便的发生率更高。 与高加索人相比。这些观察背后的机制还没有被很好地理解。 我们已经证明,线粒体功能是骨骼肌支持行走速度的关键属性, 老年人的身体机能和心肺功能。横断面和纵向研究表明 线粒体含量和功能降低,心肺功能减退,行走速度减慢 随着年龄的增长。我们最近在非裔美国人中发现骨骼肌线粒体功能降低。 与高加索女性相比,这与心血管健康和代谢率较低有关。 线粒体DNA(MtDNA)在与年龄相关的肌肉氧化能力变化中的作用尚不清楚 探索过了。我们新的初步数据表明,mtdna单倍型是LOW的一个重要决定因素。 非裔美国人的线粒体功能和心血管健康状况。我们还证明了线粒体DNA 在AA和C年龄较大的成年人中,变异与步行速度有关。此外,最近的研究表明 研究表明,运动训练后VO2峰值的变化与mtDNA有关 单倍群。基于这些观察结果,我们推测mtdna单倍型在 横断面变异,更重要的是,线粒体功能纵向下降,心血管 老年人的健康状况和步行速度。线粒体DNA的变异已被证明影响衰老 表型可分为1)遗传变体,它们是母系遗传的单核苷酸 多态(SNP),其中许多区分mtDNA单倍群,许多不区分,或2) 获得性变异,包括异质性,或在任何位置突变与正常mtDNA的百分比 基因组和线粒体DNA拷贝数随年龄增长而减少。 这项对肌肉、活动能力和衰老研究的辅助研究将探索遗传和获得性的作用 在一大群表型良好的肌肉活检中线粒体功能的线粒体DNA变异 人类。我们还将探讨核编码线粒体蛋白(NEMP)和串扰的作用 观察到线粒体DNA与核DNA在线粒体和生理上的差异。我们 将这些发现与整个队列中移动性的临床重要终点以及在 非洲裔美国人的流动性下降幅度越大。 我们的研究将首次表明线粒体DNA变异预示着线粒体和 生理功能,与行动不便有关。这些发现可以让我们评估 使用简单的抽血来识别低功能风险人群的线粒体DNA变异,并实施有针对性的 已被证明可以改善线粒体功能的治疗方法,如体力活动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul Martin Coen其他文献

Paul Martin Coen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul Martin Coen', 18)}}的其他基金

Impact of mitochondrial genetics on muscle oxidative capacity, fitness, and mobility in older adults
线粒体遗传学对老年人肌肉氧化能力、健康和活动能力的影响
  • 批准号:
    10705262
  • 财政年份:
    2022
  • 资助金额:
    $ 47.08万
  • 项目类别:
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.
BAT 作为治疗衰老代谢和心脏功能障碍的药物。
  • 批准号:
    10355418
  • 财政年份:
    2019
  • 资助金额:
    $ 47.08万
  • 项目类别:
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.
BAT 作为治疗衰老代谢和心脏功能障碍的药物。
  • 批准号:
    10557231
  • 财政年份:
    2019
  • 资助金额:
    $ 47.08万
  • 项目类别:
BAT as a therapeutic for the metabolic and cardiac dysfunction with senescence.
BAT 作为治疗衰老代谢和心脏功能障碍的药物。
  • 批准号:
    10092058
  • 财政年份:
    2019
  • 资助金额:
    $ 47.08万
  • 项目类别:
The role of type 2 diabetes on skeletal muscle atrophy and recovery following bed rest in older adults
2 型糖尿病对老年人卧床休息后骨骼肌萎缩和恢复的作用
  • 批准号:
    10412070
  • 财政年份:
    2018
  • 资助金额:
    $ 47.08万
  • 项目类别:
The role of type 2 diabetes on skeletal muscle atrophy and recovery following bed rest in older adults
2 型糖尿病对老年人卧床休息后骨骼肌萎缩和恢复的作用
  • 批准号:
    9765131
  • 财政年份:
    2018
  • 资助金额:
    $ 47.08万
  • 项目类别:
The role of type 2 diabetes on skeletal muscle atrophy and recovery following bed rest in older adults
2 型糖尿病对老年人卧床休息后骨骼肌萎缩和恢复的作用
  • 批准号:
    10231270
  • 财政年份:
    2018
  • 资助金额:
    $ 47.08万
  • 项目类别:
Ceramide Mediated Oxidative Stress in Muscle Loss with Aging and Disuse
神经酰胺介导的氧化应激导致衰老和废用性肌肉损失
  • 批准号:
    8727434
  • 财政年份:
    2013
  • 资助金额:
    $ 47.08万
  • 项目类别:
Ceramide Mediated Oxidative Stress in Muscle Loss with Aging and Disuse
神经酰胺介导的氧化应激导致衰老和废用性肌肉损失
  • 批准号:
    8867115
  • 财政年份:
    2013
  • 资助金额:
    $ 47.08万
  • 项目类别:
Ceramide Mediated Oxidative Stress in Muscle Loss with Aging and Disuse
神经酰胺介导的氧化应激导致衰老和废用性肌肉损失
  • 批准号:
    8486746
  • 财政年份:
    2013
  • 资助金额:
    $ 47.08万
  • 项目类别:

相似海外基金

Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10818088
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers in African Americans
非裔美国人冠心病和相关代谢组标记物的混合图谱
  • 批准号:
    10571022
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
  • 批准号:
    10590405
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
NSF Postdoctoral Fellowship in Biology: Coalescent Modeling of Sex Chromosome Evolution with Gene Flow and Analysis of Sexed-versus-Gendered Effects in Human Admixture
NSF 生物学博士后奖学金:性染色体进化与基因流的合并模型以及人类混合中性别与性别效应的分析
  • 批准号:
    2305910
  • 财政年份:
    2023
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Fellowship Award
Admixture mapping of mosaic copy number alterations for identification of cancer drivers
用于识别癌症驱动因素的马赛克拷贝数改变的混合图谱
  • 批准号:
    10608931
  • 财政年份:
    2022
  • 资助金额:
    $ 47.08万
  • 项目类别:
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients
利用微生物组、局部混合物和机器学习来优化医疗服务不足的患者的抗凝药物基因组学
  • 批准号:
    10656719
  • 财政年份:
    2022
  • 资助金额:
    $ 47.08万
  • 项目类别:
The role of admixture in human evolution
混合物在人类进化中的作用
  • 批准号:
    10683318
  • 财政年份:
    2022
  • 资助金额:
    $ 47.08万
  • 项目类别:
Genealogical ancestors, admixture, and population history
家谱祖先、混合和人口历史
  • 批准号:
    2116322
  • 财政年份:
    2021
  • 资助金额:
    $ 47.08万
  • 项目类别:
    Standard Grant
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10307040
  • 财政年份:
    2021
  • 资助金额:
    $ 47.08万
  • 项目类别:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
非裔美国儿童急性淋巴细胞白血病的混合分析:ADMIRAL 研究
  • 批准号:
    10307680
  • 财政年份:
    2021
  • 资助金额:
    $ 47.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了